Products & Programs
Miraculins is dedicated to the development of diagnostic tools for a select group of cancers that are notoriously difficult to diagnose, with current diagnostic options resulting in numerous false positives and false negatives, at considerable cost to patients.
Research & Technology
The objective of Miraculins' diagnostic program is to identify particular proteins or peptides whose presence in bodily fluids indicates the absence or presence of a specific cancer. The Company carefully analyzes biological samples in our laboratory in search of subtle biological differences.
A given biological sample can easily contain tens of thousands of different protein molecules; Miraculins' approach allows it to direct attention to the molecules of interest for their diagnostic capabilities. This is particularly relevant as the evidence mounts supporting early detection of cancer to improve patient outcomes.